6 JAN - FEB 2026Regenerative medicine is reshaping plastic surgery across the APAC region, shifting the industry from artificial augmentation to biologically driven, patient-centered solutions. This edition explores how safety, clinical rigor, and lasting outcomes are redefining aesthetic and reconstructive care.At the center of this discussion is Kuno Clinic, recognized as the Top Plastic Surgery Regenerative Medicine Service in APAC 2026. Led by Dr. Hiroo Kuno, the clinic has distinguished itself through its in vivo regenerative medicine approach, introduced in 2007, which replaces excisional surgery and synthetic materials with autologous solutions using adipose-derived stem cells, platelet-rich plasma, and targeted nutritional support to enable controlled, natural tissue regeneration. This model directly overcomes the short-lived and often unnatural outcomes associated with conventional facelifts and thread lifts.Kuno Clinic's long-term impact is defined by technical precision and continuous refinement. Through advanced adaptations of VASER ART 4D technology for regenerative use, it has expanded the scope of aesthetic correction, from revising unsuccessful procedures to achieving durable rejuvenation across the face and body. A consistent focus on minimal incisions, avoidance of foreign substances, and end-to-end surgical oversight underscores its commitment to safety and patient-specific outcomes, firmly establishing its leadership in regenerative aesthetics.This issue also features CXO perspectives that provide context for innovation across the broader healthcare ecosystem. Winny Xie, Molecular Predictive and Diagnostic Lab Head at PT Prodia Widyahusada Tbk, examines how molecular diagnostics, sequencing technologies, and advanced laboratory capabilities are improving prognostic accuracy while managing cost and operational complexity. In parallel, Janene Lawrence, Clinical Nurse Manager (Medical) at Hutt Valley DHB, addresses how we must demonstrate a culture of kindness within ourselves and have the courage to move in directions that will allow opportunities to grow health professionals and always put the people first.Collectively, these narratives highlight how leadership, clinical rigor, and thoughtful innovation are shaping the future of healthcare. Readers are encouraged to explore the full articles to better understand how regenerative medicine and strategic stewardship continue to raise standards across the industry.Let us know your thoughts!Transforming Aesthetics with Regenerative MedicineEDITORIALManaging EditorAlex D'souzaEditorial StaffAaron PaulGina ClumskyJoe PhillipJames SmithMark RobertYenny TurnerCopyright © 2026 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@healthcarebusinessreview.comeditor@healthcarebusinessreview.commarketing@healthcarebusinessreview.comVisualizersVictor CruzEdwin PaulJAN - FEB 2026, Volume 09 - Issue 02 ValleyMedia, Inc. (ISSN 2836-7030)To subscribe to Healthcare Business ReviewVisit www.healthcarebusinessreview.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsAlex D'souzaManaging Editoreditor@healthcarebusinessreview.com
< Page 5 | Page 7 >
< Page 5 | Page 7 >